Biodistribution and pharmacokinetics of ¹⁸⁸Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice

References

• EisenbergBDecosseJJHarfordFMichalekJCarcinoma of the colon and rectum: the natural history reviewed in 1704 patientsCancer1982496113111347059938
   PubMed Web of Science ®Google Scholar
• GallagherDJKemenyNMetastatic colorectal cancer: from improved survival to potential cureOncology2010783–423724820523084
   PubMed Web of Science ®Google Scholar
• CarmignaniCPSugarbakerTABromleyCMSugarbakerPHIntraperitoneal cancer dissemination: mechanisms of the patterns of spreadCancer Metastasis Rev200322446547212884919
   PubMedGoogle Scholar
• PestieauSRSugarbakerPHTreatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs delayed managementDis Colon Rectum2000431013411346 discussion 1347–134811052509
   PubMed Web of Science ®Google Scholar
• SoodRAscites: Diagnosis and ManagementJIACM2000518189
   Google Scholar
• HegdeSRSunWLynchJPSystemic and targeted therapy for advanced colon cancerExpert Rev Gastroenterol Hepatol20082113514919072376
   PubMedGoogle Scholar
• WolpinBMMayerRJSystemic treatment of colorectal cancerGastroenterology200813451296131018471507
   PubMed Web of Science ®Google Scholar
• Gomez PortillaACendoyaILopez de TejadaIPeritoneal carcinomatosis of colorectal origin. Current treatment. Review and updateRev Esp Enferm Dig2005971071673716351464
   PubMedGoogle Scholar
• Novotny-DiermayrVSangthongpitagKHuCYSB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancerMol Cancer Ther20109364265220197387
   PubMed Web of Science ®Google Scholar
• Gil-AdIZolokovALomnitskiLEvaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted miceInt J Oncol200833227728618636148
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
   PubMed Web of Science ®Google Scholar
• NewmanMSColbernGTWorkingPKEngbersCAmanteaMAComparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing miceCancer Chemother Pharmacol1999431179923534
   PubMed Web of Science ®Google Scholar
• VaageJDonovanDWipffETherapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomesInt J Cancer19998011341379935243
   PubMed Web of Science ®Google Scholar
• UldrickTSWhitbyDUpdate on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi SarcomaCancer Lett2011305215016221377267
   PubMed Web of Science ®Google Scholar
• Gonzalez MartinASafety profile of trabectedin in combination with liposomal pegylated doxorrubicin in relapsed ovarian carcinoma: considerations for optimal managementInt J Gynecol Cancer20112110 Suppl 1S6821540668
   PubMed Web of Science ®Google Scholar
• CobleighMAOther options in the treatment of advanced breast cancerSemin Oncol201138Suppl 2S111621600380
   PubMed Web of Science ®Google Scholar
• EmfietzoglouDKostarelosKSgourosGAn analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapyJ Nucl Med200142349950411337529
   PubMed Web of Science ®Google Scholar
• TingGChangCHWangHECancer nanotargeted radiopharmaceuticals for tumor imaging and therapyAnticancer Res200929104107411819846958
   PubMed Web of Science ®Google Scholar
• TsengYLHongRLTaoMHChangFHSterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma modelInt J Cancer199980572373010048974
   PubMed Web of Science ®Google Scholar
• ChangYJChangCHChangTJBiodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-BMEDA-liposome in a C26 murine colon carcinoma solid tumor animal modelAnticancer Res2007274B2217222517695506
   PubMed Web of Science ®Google Scholar
• CaoSRustumYMSynergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and doseCancer Res200060143717372110919639
   PubMed Web of Science ®Google Scholar
• MooreMHirteHWSiuLPhase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumorsAnn Oncol200516101688169416006586
   PubMed Web of Science ®Google Scholar
• YonemuraYFujimuraTFushidaSHyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal disseminationWorld J Surg1991154530535 discussion 535–5361891941
   PubMed Web of Science ®Google Scholar
• JayneDMolecular biology of peritoneal carcinomatosisCancer Treat Res2007134213317633045
   PubMedGoogle Scholar
• ChenLCChangCHYuCYBiodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse modelNucl Med Biol200734441542317499731
   PubMed Web of Science ®Google Scholar
• ChenLCChangCHYuCYPharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice modelNucl Med Biol200835888389319026950
   PubMed Web of Science ®Google Scholar
• BallyMBMasinDNayarRCullisPRMayerLDTransfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceCancer Chemother Pharmacol19943421371468194164
   PubMed Web of Science ®Google Scholar
• GabizonAASelective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesCancer Res19925248918961737351
   PubMed Web of Science ®Google Scholar
• MassoudTFGambhirSSMolecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes Dev200317554558012629038
   PubMed Web of Science ®Google Scholar
• ChangCHWangHEWuSYComparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in miceAnticancer Res2006262A91792516619487
   PubMed Web of Science ®Google Scholar
• ChangCHJanMLFanKHLongitudinal evaluation of tumor metastasis by an FDG-microPet/microCT dual-imaging modality in a lung carcinoma-bearing mouse modelAnticancer Res2006261A15916616475693
   PubMed Web of Science ®Google Scholar
• ZavaletaCLPhillipsWTBradleyYCMcManusLMJerabekPAGoinsBACharacterization of an intraperitoneal ovarian cancer xenograft model in nude rats using noninvasive microPET imagingInt J Gynecol Cancer200717240741717362319
   PubMed Web of Science ®Google Scholar
• FisherDRAssessments for high dose radionuclide therapy treatment planningRadiat Prot Dosimetry20031051–458158614527031
   PubMed Web of Science ®Google Scholar
• MaceyDJMeredithRFA strategy to reduce red marrow dose for intraperitoneal radioimmunotherapyClin Cancer Res1999510 Suppl3044s3047s10541341
   PubMed Web of Science ®Google Scholar
• SafraTGroshenSJeffersSTreatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcomeCancer20019119010011148564
   PubMed Web of Science ®Google Scholar
• HarringtonKJMohammadtaghiSUsterPSEffective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomesClin Cancer Res20017224325411234875
   PubMed Web of Science ®Google Scholar
• LimHJMasinDMcIntoshNLMaddenTDBallyMBRole of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsJ Pharmacol Exp Ther2000292133734510604968
   PubMed Web of Science ®Google Scholar
• HarringtonKJRowlinson-BuszaGSyrigosKNInfluence of tumour size on uptake of 111ln-DTPA-labelled pegylated liposomes in a human tumour xenograft modelBr J Cancer200083568468810944612
   PubMed Web of Science ®Google Scholar
• SugarbakerPHObservations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiologyCancer Treat Res199682791008849945
   PubMedGoogle Scholar
• AdamRAAdamYGMalignant ascites: past, present, and futureJ Am Coll Surg20041986999101115194082
   PubMed Web of Science ®Google Scholar